Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment

被引：89
|
作者：
Fioretto, Paola [1 ]
Stefansson, Bergur V. [2 ]
Johnsson, Eva [2 ]
Cain, Valerie A. [3 ]
Sjostrom, C. David [2 ]
机构：
[1] Univ Padua, Dept Med, Clin Med 3, Via Giustiniani 2, I-35128 Padua, Italy
[2] AstraZeneca, Molndal, Sweden
[3] AstraZeneca, Wilmington, DE USA
来源：
DIABETOLOGIA | 2016年 / 59卷 / 09期
关键词：
Albuminuria; Dapagliflozin; Renal impairment; SGLT2; inhibition; Type; 2; diabetes; BLOOD-PRESSURE;
D O I：
10.1007/s00125-016-4017-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2036 / 2039
页数：4
相关论文
共 50 条
  • [31] The relationship between hypomagnesemia and albuminuria in patients with type 2 diabetes mellitus
    Eker, Edibe S.
    Ataoglu, Hayriye E.
    [J]. CLINICAL ENDOCRINOLOGY, 2024, 101 (03) : 216 - 222
  • [32] The Effects of Calcitriol on Albuminuria in Patients with Type-2 Diabetes Mellitus
    Bonakdaran, Shokoufeh
    Hami, Maryam
    Hatefi, Asieh
    [J]. SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2012, 23 (06) : 1215 - 1220
  • [33] Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years
    Wilding, J. P. H.
    Woo, V.
    Rohwedder, K.
    Sugg, J.
    Parikh, S.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (02): : 124 - 136
  • [34] ANTIDIABETIC MEDICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND SEVERE RENAL IMPAIRMENT: AN UPDATE
    Aperis, Georgios
    [J]. JOURNAL OF RENAL CARE, 2012, 38 (03) : 170 - 171
  • [35] Lixisenatide Is Effective and Well Tolerated in Patients with Type 2 Diabetes Mellitus and Renal Impairment
    Gomez-Huelgas, Ricardo
    Ambos, Anu
    Arteaga, Juan M.
    Leiter, Lawrence A.
    Marchesini, Giulio
    Nikonova, Elena
    Shestakova, Marina
    Stager, William
    Tambascia, Marcos
    Hanefeld, Markolf
    [J]. DIABETES, 2014, 63 : A254 - A255
  • [36] Lixisenatide is effective and well tolerated in patients with type 2 diabetes mellitus and renal impairment
    Hanefeld, M.
    Ambos, A.
    Arteaga, J.
    Leiter, L. A.
    Marchesini, G.
    Nikonova, E.
    Shestakova, M.
    Stager, W.
    Tambascia, M.
    Gomez Huelgas, R.
    [J]. DIABETOLOGIA, 2014, 57 : S341 - S342
  • [37] Saxagliptin/Dapagliflozin: A Review in Type 2 Diabetes Mellitus
    Karly P. Garnock-Jones
    [J]. Drugs, 2017, 77 : 319 - 330
  • [38] Dapagliflozin for the treatment of type 2 diabetes mellitus - an update
    Nicholson, Martha K.
    Ghazal Asswad, Randa
    Wilding, John P. H.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (17) : 2303 - 2310
  • [39] Saxagliptin/Dapagliflozin: A Review in Type 2 Diabetes Mellitus
    Garnock-Jones, Karly P.
    [J]. DRUGS, 2017, 77 (03) : 319 - 330
  • [40] Dapagliflozin combination therapy in type 2 diabetes mellitus
    Yacoub, Tamer
    [J]. POSTGRADUATE MEDICINE, 2016, 128 (01) : 124 - 136
12345